News & Updates

New drug applications approved by US FDA as of 16-30 November 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

A recent study has observed a very high recurrence rate for cytomegalovirus (CMV) anterior uveitis (AU), but this can be resolved by antiviral therapy.

Individuals with blue light-filtering (BLF) intraocular lenses (IOLs) appear to have a higher risk of depressive disorders than those with clear IOLs, reveals a study.

The significantly poorer health-related quality of life (HRQoL) in patients with chronic vertigo and dizziness compared with those without, following a stroke, necessitates systematic poststroke screening, comprehensive multidisciplinary assessment and individualized rehabilitation, according to a stroke cohort study.

Female sex appears to be an independent risk factor for hip fracture among individuals with inflammatory bowel disease (IBD), findings from a nationally representative study suggest.

Routine use of antibiotic prophylaxis does not appear to improve outcomes in children undergoing laparoscopic orchiopexy, reveals a recent study.